Previous 10 | Next 10 |
Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer PR Newswire Submission based on data from Phase 2b HERIZON-BTC-01 trial, which met its primary endpoint in patients receiving zanid...
Oncology is a tricky sector in which to innovate, but we can start by optimizing existing combination approaches NORTHAMPTON, MA / ACCESSWIRE / March 28, 2024 / Jazz Pharmaceuticals By Liz Henderson Liz Henderson, Sr. Vice President Technical Operations at Jazz Pharmaceuticals discusses...
2024-03-23 17:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-20 13:30:07 ET UBS analyst issues BUY recommendation for JAZZ on March 20, 2024 10:00AM ET. The previous analyst recommendation was Buy. JAZZ was trading at $124.43 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst r...
2024-03-20 11:30:01 ET RBC Capital analyst issues UNDERPERFORM recommendation for JAZZ on March 20, 2024 10:00AM ET. The previous analyst recommendation was Underperform. JAZZ was trading at $124.43 at issue of the analyst recommendation. The overall analyst consensus : ...
NORTHAMPTON, MA / ACCESSWIRE / March 20, 2024 / Jazz Pharmaceuticals Originally published by Jazz Pharmaceuticals To mark International Women's Day, JAWS (Jazz Association of Women Supporters), the affinity forum created to promote the advancement and impact of women globally in the innovati...
NORTHAMPTON, MA / ACCESSWIRE / March 14, 2024 / Jazz Pharmaceuticals Originally published by Jazz Pharmaceuticals on LinkedIn In honor of U.S. Black History Month, JazzSoul, the affinity forum created to support Black employees and their allies and foster inclusive conversations at Jazz, cel...
Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024 Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024 PR Newswire DUBLIN , March 12, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasda...
2024-03-05 14:00:00 ET Summary Avadel's stock rose 51% post-buy recommendation, buoyed by Q4 earnings and a favorable royalty rate judgment versus Jazz Pharmaceuticals. Lumryz's market penetration and unique once-nightly dosing advantage are driving optimistic revenue forecasts an...
2024-03-03 02:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Jazz Pharmaceuticals plc Company Name:
JAZZ Stock Symbol:
NASDAQ Market:
Jazz Pharmaceuticals plc Website:
Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026 PR Newswire DUBLIN , July 22, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ...
Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2024 second quarter financial results on Wed...